Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HIALSORB Cold is a topical massage gel developed by TRB Chemedica (TRB Middle East) designed for the relief of joint and muscle discomfort, particularly following physical exertion or minor injury. The formulation combines **hyaluronic acid** and **chondroitin sulfate** with **menthol** to provide a dual-action approach: immediate cooling relief and localized tissue support. Menthol acts as a topical analgesic by stimulating the TRPM8 cold receptors, creating a cooling sensation that masks pain signals. Hyaluronic acid and chondroitin sulfate are key glycosaminoglycans found in synovial fluid and cartilage; in this topical format, they are intended to support the structural integrity and lubrication of the tissues surrounding the joints. The product is marketed primarily for athletes and individuals suffering from joint stiffness or inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HIALSORB Cold.